SCHEMBL7985285

SCHEMBL7985285

O=c1[nH]c(-c2ccccn2)nc2ncn(CCc3ccccc3)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
LMNA P02545 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
GAA P10253 1/20 0.47
HIF1A Q16665 1/20 0.47
CNOT7 Q9UIV1 6/20 0.46
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 2/20 0.43
HPGD P15428 1/20 0.42
METAP2 P50579 2/20 0.41
METAP1 P53582 2/20 0.41
KRAS P01116 1/20 0.41
HSP90AA1 P07900 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988799 0.93 LMNA (0.54) ALDH1A1LMNAL3MBTL1HTTNPC1
SCHEMBL7985490 0.88 ALDH1A1 (0.56) ALDH1A1LMNAL3MBTL1HTTNPC1
SCHEMBL7974613 0.86 CNOT7 (0.49) ALDH1A1LMNAHTTCNOT7KDM4E
SCHEMBL7991672 0.84 CNOT7 (0.46) ALDH1A1LMNACNOT7KDM4EPOLB
SCHEMBL7985291 0.82 CNOT7 (0.54) ALDH1A1LMNAL3MBTL1HTTNPC1
SCHEMBL7986324 0.81 HPGD (0.48) ALDH1A1LMNAGAACNOT7KDM4E
SCHEMBL7974274 0.81 CNOT7 (0.45) ALDH1A1LMNAHTTCNOT7KDM4E
SCHEMBL7973869 0.81 TNKS (0.46) ALDH1A1LMNAHTTCNOT7KDM4E
SCHEMBL7974051 0.80 ALDH1A1 (0.47) ALDH1A1LMNAL3MBTL1HTTNPC1
SCHEMBL7991530 0.80 HPGD (0.48) ALDH1A1LMNAL3MBTL1HTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed